glp 1 high cholesterol for GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Who is a good candidate

Obesity, diabetes, and liver disease in relation to cardiovascular risk

It is approved for adults and children 10 years and older

Fewer Comorbidities Affecting Capability People with diabetes are more likely to suffer from peripheral neuropathy (29.1% of T1D, 42.2% of T2D) and retinopathy (28.4% of T1D, 23.8% of T2D),14 among other things

Non-arteritic anterior ischemic optic neuropathy (NAION) is a rare eye condition that occurs when blood flow to the optic nerve becomes restricted, causing damage to the nerve fibers that transmit visual information from the retina to the brain

SOURCE: Journal of the American Medical Association , May 22, 2024 What This Means For You GLP-1 meds for diabetes and weight loss are increasingly popular among teens and young adults.

Cardiovascular benefits may include heart protection